Propanc Biopharma’s CEO Tours European CDMO & Plans for GMP Production of PRP for Phase 1b, FIH Study
Go back to Propanc Biopharma’s CEO Tours European CDMO & Plans for GMP Production of PRP for Phase 1b, FIH Study| (NASDAQ: PPCB) | Delayed: 1.01 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.01 | 52 Week High | $ | |||
| Open | $1.01 | 52 Week Low | $ | |||
| Day High | $1.01 | P/E | N/A | |||
| Day Low | $1.01 | EPS | $ | |||
| Volume | 3,818 | |||||
